Role of obesity and overweight in preeclampsia


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅或者付费存取

详细

Objective: To investigate the effect of excess body weight and obesity on preeclampsia and to compare the results with the outcomes of extended first-trimester prenatal screening. Materials and methods: The study enrolled 155 patients who were divided into Group I (n=42) and Group II (n=63) with moderate and severe preeclampsia, respectively. Group III (control group) included 50 women with healthy pregnancy. Baseline evaluation included physical, ultrasonic, and biochemical examinations as part of the combined extended prenatal screening according to Russian Health Ministry Order 1130n. Correlation analysis was performed using Gamma (Gamma, G) and Spearman (R) coefficients. Results: Overweight and obesity were found to be risk factors for gestational complications. These findings do not agree with the results of combined prenatal screening. The results of the first-trimester screening showed that 12 (11.4%) of patients in Groups I and II and five (10%) in the control group had a high risk of preeclampsia with a probability of 1:100 or higher. Correlation analysis showed a moderate association between pre-pregnancy body mass index and the development of preeclampsia during pregnancy (G=0.23, p=0.0015). Conclusion: The results of the study confirm the relationship between preeclampsia and pre-pregnancy excess body weight. Excess body weight and obesity should be classified as adverse factors that exacerbate the course and outcome of pregnancy and require 100% preventive measures regardless of the results of the first-trimester screening.

全文:

受限制的访问

作者简介

Irina Savelyeva

Omsk State Medical University, Ministry of Health of Russia

Email: saveljeva_iv_omsk@mail.ru
Dr. Med. Sci., Professor, Head of the Department of Obstetrics and Gynecology No. 1

Elena Bukharova

Omsk State Medical University, Ministry of Health of Russia

Email: buxarova88@mail.ru
Teaching Assistant at the Department of Obstetrics and Gynecology No. 1

Natalya Nosova

Omsk State Medical University, Ministry of Health of Russia

Email: natalya-nosova-85@mail.ru
Teaching Assistant at the Department of Obstetrics and Gynecology No. 1

Eugene Prodanchuk

Omsk State Medical University, Ministry of Health of Russia

PhD, Associate Professor at the Department of Obstetrics and Gynecology No. 1

Olga Tsygankova

Omsk State Medical University, Ministry of Health of Russia

Email: olts74@mail.ru
PhD, Associate Professor at the Department of Obstetrics and Gynecology No. 1

Larisa Kuklina

Omsk State Medical University, Ministry of Health of Russia

Email: kuklinalara@mail.ru
PhD, Associate Professor at the Department of Obstetrics and Gynecology No. 1

参考

  1. ACOG Practice Bulletin No. 202: Gestational hypertension and preeclampsia. Obstet. Gynecol. 2019; 133(1): e1-25. https://dx.doi.org/10.1097/ AOG.0000000000003018.
  2. Bianchi V.E. Weight loss is a critical factor to reduce inflammation. Clin. Nutr. ESPEN. 2018; 28: 21-35. https://dx.doi.org/10.1016/j.clnesp.2018.08.007.
  3. Yu L., Li Y., Du C., Zhao W., Zhang H., Yang Y. et al. Pattern recognition receptor-mediated chronic inflammation in the development and progression of obesity related metabolic diseases. Mediators Inflamm. 2019; 2019: 5271295. https://dx.doi.org/10.1155/2019/5271295.
  4. Диагностика, лечение, профилактика ожирения и ассоциированных с ним заболеваний. Национальные клинические рекомендации. СПб.; 2017: 7-10.
  5. Domokos G. Hyperglycemia-induced endothelial dysfunction. In: Endothelial dysfunction - old concepts and new challenge. Intechopen; 2018: 179-210. 10.5772/intechopen.68656.
  6. Echeverria C., Eltit F., Santibanez J.F., Gatica S., Cabello-Verrugio C., Simon F. Endothelial dysfunction in pregnancy metabolic disorders. Biochim. Biophys. Acta Mol. Basis Dis. 2020; 1866(2): 165414. https://dx.doi.org/10.1016/j.bbadis.2019.02.009.
  7. World Health Organization. Trends in maternal mortality 2000 to 2017: estimates by WHO, UNICEF, UNFRA, World Bank Group and the United Nations Population Division: executive summary. WHO; 2019. Available at: https://apps.who.int/iris/handle/10665/327596.
  8. Ottanelli S., Napoli A., Clemenza S., Mecacci F., Lapolla A., Metzger B.E. Hypertension and preeclampsia in pregnancy complicated by diabetes. Gestational diabetes. A Decade after the HAPO Study. Front. Diabetes. 2020; 28: 171-82. https://dx.doi.org/10.1159/000480173.
  9. Yonekura Collier A.R., Zsengeller Z., Pernicone E., Salahuddin S., Khankin E.V., Karumanchi S.A. Placental sFLT1 is associated with complement activation and syncytiotrophoblast damage in preeclampsia. Hypertens. Pregnancy. 2019; 38(3): 193-9. https://dx.doi.org/10.1080/10641955.2019.1640725.
  10. Дубровина С.О., Муцалханова Ю.С., Васильева В.В. Ранние предикторы преэклампсии. Акушерство и гинекология. 2018; 10: 47-51. [Dubrovina S.O., Mutsalkhanova Yu.S., Vasilyeva V.V. Early predictors of preeclampsia. Obstetrics and Gynecology. 2018; 10: 47-51. (in Russian)]. https://dx.doi.org/10.18565/aig.2018.10.47-51.
  11. Липатов И.С., Тезиков Ю.В., Азаматов А.Р., Шмаков Р.Г. Общность клинических проявлений преэклампсии и метаболического синдрома: поиск обоснования. Акушерство и гинекология. 2021; 3: 81-9. [Lipatov I.S., Tezikov Yu.V., Azamatov A.R., Shmakov R.G. The commonality of clinical manifestations of preeclampsia and metabolic syndrome: the search for justification. Obstetrics and Gynecology. 2021; 3: 81-9. (in Russian)]. https://dx.doi.org/10.18565/aig.2021.3.81-89.
  12. Нагоев Т.М., Муминова К.Т., Ходжаева З.С., Холин А.М., Зиганшина М.М., Козлова А.А., Мартиросян Я.О. Материнская гемодинамика и пре-эклампсия. Акушерство и гинекология. 2020; 1: 5-11. [Nagoev T.M., Muminova K.T., Khodzhaeva Z.S., Kholin A.M., Ziganshina M.M., Kozlova A.A., Martirosyan Ya.O. Maternal hemodynamics and preeclampsia. Obstetrics and Gynecology. 2020; 1: 5-11. (in Russian)]. https://dx.doi.org/10.18565/aig.2020.1.5-11.
  13. Преэклампсия. Эклампсия. Отеки, протеинурия и гипертензивные расстройства во время беременности, в родах и послеродовом периоде. Клинические рекомендации. М.; 2021.
  14. Приказ Минздрава России от 20.10.2020 №1130н Об утверждении Порядка оказания медицинской помощи по профилю акушерство и гинекология (зарегистрировано в Минюсте России 12.11.2020 № 60869)
  15. The Fetal Medicine Foundation. Protocol for measurement of uterine artery pulsatility index. Available at: https://fetalmedicine.org/research/assess/preeclampsia/background
  16. Ходжаева З.С., Тимошина И.В., Дегтярева Е.И., Снеткова Н.В., Потапова А.А. Влияние ожирения и чрезмерной прибавки массы тела на исходы родов. Акушерство и гинекология. 2018; 9: 62-6. https://dx.doi.org/10.18565/aig.2018.9.62-66.
  17. Шалина Р.И., Касум-заде Н.К., Коноплянников А.Г., Латышкевич О.А., Шеховцов Д.Б. Прогнозирование и профилактика преэклампсии в условиях городского центра планирования семьи и репродукции. Акушерство и гинекология. 2020; 7: 61-70. https://dx.doi.org/10.18565/aig.2020.7.61-70.

补充文件

附件文件
动作
1. JATS XML

版权所有 © Bionika Media, 2022
##common.cookie##